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Effect of piracetam, thiocetam and interleukin-
1 receptor antagonist (IL-1ra) (7.5 mg/kg) on the values
of thiol-disulfide system (TDS) and protein oxidative
modification   (POM)   was   studied   based   on   the   rat
alloxan diabetes  model. It  is established that  post-
ischemic damage to brain tissue of the experimental
animals was followed by multidirectional thiol-disulfide
imbalance (increase in levels of oxidized forms of
glutathione and  thiols  on the  background  of sharp
decrease in their reduced forms), decreased activity of
TDS enzymes (glutathione peroxidase and glutathione
reductase) and increased level of POM markers – APhH
and KhH. It  is  proved that  course introduction of
piracetam,   thiocetam   and   IL-1ra   was   beneficial   in
stabilizing TDS and POM values, normalizing activity
of glutathione peroxidase and glutathione reductase,
with maximum activity noted for IL-1ra.
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Diabetes   mellitus   (DM)   is   one   of   7   main
mortality causes in most countries of the world and is
third   among   immediate   causes   of   death   after
cardiovascular and oncological diseases [1]. In Ukraine,
a steady increase of DM prevalence is noted – a number
of diabetic patients has increased more than by half for
the past 10 years and now makes up nearly 1 million
people. Therefore solution to the DM therapy problems
is still pressing medical and social issue. [2]. Nowadays,
a body of evidence is amassed in the whole world, as to
the   fact   that   effective   DM   control   determines   life
expectancy   of   the   patients   and   their   performance
capability, as well as may keep development of the
related complications to a minimum. 
High incidence rate of DM complications is
determined by tissue metabolism with the damage to
microcapillary organ bed, which causes  multi-organ
pathology. In case of DM, insulin deficiency causes
carbohydrate,   fat   and   protein   metabolism   disorder,
trigger hyperglycemia, insulin resistance and energy
deficiency, activation of synthesis of reactive oxygen
intermediates,   free   radicals   and   products   of   lipid
peroxidation, i.e. creates pathophysiological picture of
the oxidant stress. In its turn, oxidant stress causes
increase in leukocyte adhesion, platelet aggregation and
generation   of   endothelial   dysfunction.   Metabolic
diabetic endothelial dysfunction is a release mechanism
for development of angiopathies, including neurological
complications of DM:  micro- and macroangiopathies,
encephalopathies,   cerebrovascular   disorders,   distal
neuropathies [3]. Furthermore, vascular changes induce
ischemic/hypoxic   tissue   disorders,   and   metabolic
disorders cause immediate damage and death of cell
structures of the central nervous system and peripheral
nervous system. This leads to the changes of functional
metabolic   state   of   cells,   which   are   determined   by
generation   of   mitochondrial   dysfunction,   energy
deficiency and development of the bioenergetic (tissue)
hypoxia  [4].  Therefore,   due  to  DM   metabolic  and
vascular   disorders   mutually   potentiate   their   own
pathophysiological  effects  and complete the vicious
circle of multi-system organ damage – processes of
vascular   wall   and   highly   metabolic   tissue   damage
worsen,   which   ensures   early   development   of   the
neurological complications. Thus, primary goal of the
effective   DM   therapy   is   to   block   interdependent
mechanisms of DM progression – vascular, metabolic
events and oxidant stress phenomenon, for which reason
increasingly greater attention is paid to medications
with antioxidant effect.
It is proved, that the most important biological
role for antioxidant system is played by reduction-
oxidation reactions, during which thiol groups are easily
oxidized, generally to form disulfide groupings, and
again are regenerated under their reductive splitting.
Based   on   such   transformations,   a   reversible   thiol-
disulfide system (TDS) is formed. TDS intermediates
exhibit transport properties as to nitrogen oxide (NO),
thus increasing its bioavailability. Besides, many thiols
–   glutathione,   cysteine,   methionine   –   are   able   to
considerably   limit   cytotoxicity   of   NO   and   its
derivatives, thus multiplying neuron chances to survive
in case of ischemia [5]. 
Agents, providing both for damaging effect and
cell   viability   system   in   the   ischemia/hypoxia   area,
include   cytokines   –   intercellular   communication
transmitters   in   health   and   disease,   which   establish
communication signal network between cells of the
immune system and cells of other organs and tissues.
According   to   present-day   ideas,   nature   of   immune
response   and   peculiarities   of   development   of   the
pathophysiological changes in ischemic/hypoxic tissue
disorders depends on preemptive activation of the T-
lymphocyte subpopulations, their synthesis of cytokines
of various types and formation of "cytokine cascade",
i.e.   relation   between   pro-inflammatory   and   anti-
inflammatory cytokines [6]. Therefore, application of
cytokine preparations may become effective perspective
link   in   the   complex   therapy   of   port-ischemic
complications in DM. 
Research objective is to study changes in TDS
and protein oxidative modification (POM) measures in
the brain  tissue  of rats  with experimental  diabetes
mellitus   when   using   metabolic   cerebroprotectors,     35
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piracetam,   thiocetam   and   cytokine   preparation   –
recombinant interleukin-1 receptor antagonist (IL-1ra).
Materials and methods 
Interleukin-1 receptor antagonist (IL-1ra) was
obtained in the Saint-Petersburg Research Institute of
Especially Pure Biopreparations by gene transformation
of E.coli. The study was conducted on 50 white Wistar
rats weighing 250-300 g, kept in the standard vivarium
conditions and divided into 5 groups with 10 animals in
each group [7].  First group consists of intact animals,
second group – animals with experimental diabetes
mellitus (DM, control), third group – animals with DM,
which were made intramuscular injections of 500 mg/kg
of piracetam once a day (group DM+Piracetam), fourth
group   –   animals   with   DM,   which   were   made
intramuscular injections of 500 mg/kg of thiocetam
once a day (group DM+Thiocetam), and fifth group –
animals  with DM, which were  made intramuscular
injections of 7.5mg/kg of IL-1ra once a day (group
DM+IL-1ra).   Throughout   the   duration   of   research,
animals from the first and second groups were injected a
sterile   saline   solution   in   the   relevant   volume
intramuscularly. Experimental diabetes was simulated
by means  of single subcutaneous  administration of
alloxan monohydrate water solution (Sigma, USA) –
150 mg/kg as 5% acetate buffer solution with pH 4.5.
This solution was administered after preliminary 24-
hour food deprivation with allowed access to water. In
order to generate full and stable diabetes, the animals
were put on a standard diet . Blood glucose level was
determined on the 3th day after alloxan administration
using glucose meter Optium Omega (Abbot Diabetes
Care Inc., USA). For further researches, only animals
with high glucose level (> 11 mmol/l) were used.  
Brain   tissue   fragments   from   mesencephalic
artery region, homogenized in liquid nitrogen, were
used as materials for biochemical researches.  Cytosolic
fraction  was  separated  by differential  centrifugation
(15,000 g) at the temperature of +4ºС on phosphate
buffer 0.15 М with pH 7.8. Protein-free extract was
obtained   by   adding   exact   amount   of   brain   tissue
homogenate into perchloric acid (0.6 M) followed by
neutalization by 5.0 M of potassium carbonate. To study
thiol-sulfide  system   activity  in  the   rat  brain   tissue
homogenate, levels of reduced and oxidized thiols and
glutathione, and activity of glutathione peroxidase (GP)
and   glutathione   reductase   (GR)   were   determined.
Content   of   total   SH-groups   were   measured   by
spectrophotometry [8]. Concentration of reduced and
oxidized glutathione was measured by fluorometry [9].
Activity of TDS enzymes – GP and GR – was measured
by spectrophotometry [10]. Content of methionine and
cysteine   in   the   homogenate   was   measured   by
chromatography [8]. Also, using biochemical methods,
content of protein oxidative modification products was
measured in the brain homogenate by levels of aldehyde
(APhH) and carboxyle (KphH) products [11]. Statistical
data processing was carried out by means of Statistica
6.0 software package; comparative group analysis was
performed by means of one-way analysis of variance
ANOVA   using   Newman–Keuls   test   for   multiple
comparisons. Differences with  р<0.05 were considered
statistically significant.
Results and discussion
As a result of research, we found out that thiol-disulfide
balance is disturbed at the generation of alloxan diabetes
(Fig. 1). 
Fig. 1 Values of reduced (SH) and oxidized (SS) thiols, and reduced (GSH) and oxidized (OSSG) glutathione in
the brain tissue of DM rats
Notes for Fig. 1-4: Intact – intact rats; DM – diabetes
mellitus;   DM+Piracetam   –   diabetes   mellitus   +
Piracetam;  DM + Thiocetam  – diabetes  mellitus +
Thocetam; DM + IL-1ra – diabetes mellitus + IL-1ra.
Statistically significant differences (р<0,05) for intact
rates  are  marked  with  "I",  for   rates  with  diabetes
mellitus – with "D", for rats from DM+Piracetam group     36
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– with "P", for rates from DM + Thiocetam group –
with "T".
For   animals   with   DM,   an   expressed
disproportion was noted – increase as to the intact
animal measures for oxidized thiol levels by 5.7 times
and   for   oxidized   glutathione   levels   by   2.7   times
(р<0,001) on the background of sharp decrease  of
reduced thiols and glutathione, which proves expressed
disorder of the intracellular glutathione pool. 
Development of DM in brain homogenate of
the   experimental   animals   was   followed   by   stable
decrease   in   the   activity   of   thiol-disulfide   system
enzymes – GR by 79% and GP by 76% – as compared
to the intact animal group (Fig. 2). 
Fig. 2. Activity of glutathione reductase (GR) and glutathione peroxidase (GP) in the DM rat brain tissue
Also, development of DM in rats was followed
by   decrease   in   cysteine   and   methionine   levels   as
compared   to   the   intact   group   by   64%   and   60%
respectively on the background of sharp increase in the
levels   of   potentially   neurotoxic   substances   –
homocysteine (by 5.1 times) and nitrotyrosine (by 6
times, р<0,001), which proves development of oxidative
and nitrosating stress in the brain tissue of rats with
experimental DM (Fig. 3).
Under conditions of the experimental therapy,
the following results of piracetam, thiocetam, and IL-
1ra effect on thiol-disulfide balance (Fig. 1-3) were
obtained.   On   the   background   of   piracetam
administration, a certain stabilization in the DM rat
brain tissues was noticed for the studied TDS activity
values as compared to the control animals – levels of
oxidized thiols and glutathione were lowered by 22%
and 27% respectively (р<0,01), changes in the rest of
values were expressed in a lesser degree.
Fig. 3. Content of cysteine (Cys), methionine (Met), homocysteine (Hcys) and nitrotyrosine (NTR) in the brain 
tissue of DM rats     37
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On   the   background   of   thiocetam
administration,   oxidized   glutathione   formation   is
blocked   in   the   experimental   animals   by   25%   and
formation of oxidized thiols is blocked by 39% on the
background of elevation of their reduced forms – by
27% and 43% respectively (р<0,01) – and increase in
GR and GP activity by 32-37% as compared to control
values. 
Administration of IL-1ra to the DM animals
had the most expressed affect on TDS state – levels of
oxidized thiols and glutathione were decreased by 55%
and 78% (р<0,001) respectively as compared to control
values. In this context, levels of reduced glutathione and
thiols are actively increased (to 70% of the intact
values) and activity of TDS enzymes is restored –
during acute period of diabetes activity of GR and GP is
increased almost fourfold. Furthermore, use of IL-1ra
resulted in almost equivalent decrease in the levels of
neurotoxic homocystein and nitrotyrosine in the brain
tissue  by  75%  and   78%  (р<0,001)  respectively  as
compared to control values, with cystein and methionine
levels   being   restored   nearly   to   the   intact   animal
measures. Similar dynamic for such values, yet less
expressed, was noticed for the animals from Thiocetam
group.
Ischemic   damage   to   brain   tissue   of   the
experimental   animals   with   experimental   DM   was
followed by increase of POM markers in the brain
homogenate – aldehyde phenylhydrazones (APhH) and
ketone phenylhydrazones (KPhH), which are formed
under conditions of oxidative and nitrosating stress (Fig.
4). 
Fig. 4. Content of aldehyde (APhH) and carboxyle (KPhH) products in the DM rat brain tissue.
In   our   research,   development   of   alloxan
diabetes was followed by the expressed elevation of
APhH and KPhH levels – by 131% and 124% (р<0,001)
respectively. Use of piracetam and thiocetam resulted in
significant decrease in POM markers, which is more
expressed in the thiocetam group (decrease of KphH by
36%). Course administration of IL-1ra facilitated the
most   significant   stabilization   of   protein   oxidative
modification and almost twofold decrease in its markers
in the brain tissue, with KphH nearly reaching intact
animal measures.
Therefore, in case of ischemic dmaage to the
brain tissue in DM model, TDS balance shifts due to
decrease in its reduced intermediates on the background
of   oxidized   forms,   with   considerable   lowering   of
reduced glutathione level and GR and GP activity.
Similar   pathological   biochemical   changes   cause
significant functional changes in cells and are often
irreversible. Changes on TDS activity and oxidation of
thiol groups of a cystein-dependent protein region of the
mitochondrial internal membranes cause depolarization
and   destabilization   of   the   mitochondrial   internal
membranes,   with   so   called   non-selective   PT-pore
(permeability transition pore – PTP) being formed [12].
Opening of such channel in the internal membrane
results in establishing ion balance in the matrix and
mitochondrial   intermembranous   space,   distributes
hydrogen ion gradient (Н
+) to the internal membrane
and breaks respiratory chain. Also, this causes volume
disregulation   of   mitochondria   due   to   the   matrix
hyperosmolality, results in the increased matrix volume,
breaks   of   the   external   membrane   and   growing
destabilization of mitochondria and enzyme system,
leads   to   development   of   persistent   mitochondrial
dysfunction, and as a result, to mitochondrial death –
mitoptosis. Moreover, IL-1, produced in response to
hypoxia, expresses inducible NOS (iNOS) in the glial
cells, which results in NO hyperproduction and toxic
effects die to its excessive amount.  Excessive amount
and   its  highly  toxic   derivatives  nitrosylate  protein-
clinging   enzymes   of   the   respiratory   chain   of
mitochondria and Krebs cycle, and inhibit them [13].
Dysfunction   of   mitochondrial   enzyme   complexes     38
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(MEC) is formed, which causes qualitative changes of
iron-sulfur centers in the mitochondrial enzymes and
their functions, as well as suppression of a main (NAD-
dependent)   pathway   for   the   substrate   oxidation   in
respiratory   chain.   Aerobic   energy   synthesis   is
suppressed,   thus   bioenergetic   (tissue)   hypoxia   is
developed [14].   Under conditions of the impaired
generation  of   cell  energy,   caused  by  mitochondrial
dysfunction, loss of NAD and ATP results in death of
cells   by   necrosis   or   apoptosis   [15].   These
pathophysiological   changes   form   the   basis   of
occurrence   of   early   or   late   post-ischemic   DM
complications, resulting in disturbance of the usual
lifestyle and lowering of life quality, persistent loss of
occupational capacity and rapid progression of heavy
neurological consequences up to lethal outcome. 
To gain maximum protective effect in the DM
therapy,   it   is   necessary   to   achieve   interruption   of
pathogenetic ischemic/hypoxic cascade at earlier stages,
which   includes   stage   of   thiol-disulfide   imbalance
establishing.   Normalization   of   TDS   state   allows
prevention of depolarization and destabilization of the
mitochondrial   internal   membrane   followed   by
development   of   mitochondrial   dysfunction,   energy
imbalance and other post-ischemic consequences.
Conclusions
1. Development of alloxan diabetes with onset of post-
hypoxic tissue changes was followed by the discordant
shifts of thiol-disulfide system components ((increase in
levels of oxidized forms of glutathione and thiols on the
background of sharp decrease in their reduced forms),
decreased activity of TDS enzymes, as well as increased
content of neurotoxic homocystein and nitrotyrosine and
markers of protein oxidative modification in the rat
brain.
2. Course administration of piracetam, thiocetam, and
IL-1ra facilitated stabilization of thiol-disulfide balance
and decreased activity of free radical oxidation reactions
in the DM rat brains.
3. IL-1ra activity toward normalization of thiol-disulfide
system and inhibition of manifestations of oxidative and
nitrosylate tress is higher than similar activities  of
piracetam and thiocetam.
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Agents, providing both for damaging effect and cell 
viability system in the ischemia/hypoxia area, include 
cytokines – intercellular communication transmitters in 
health and disease, which establish communication 
signal network between cells of the immune system and 
cells of other organs and tissues. According to present-     39
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day ideas, nature of immune response and peculiarities 
of development of the pathophysiological changes in 
ischemic/hypoxic tissue disorders depends on 
preemptive activation of the T-lymphocyte 
subpopulations, their synthesis of cytokines of various 
types and formation of "cytokine cascade", i.e. relation 
between pro-inflammatory and anti-inflammatory 
cytokines. Therefore, application of cytokine 
preparations may become effective perspective link in 
the complex therapy of port-ischemic complications in 
DM. In case of ischemic dmaage to the brain tissue in 
DM model, TDS balance shifts due to decrease in its 
reduced intermediates on the background of oxidized 
forms, with considerable lowering of reduced 
glutathione level and GR and GP activity. Similar 
pathological biochemical changes cause significant 
functional changes in cells and are often irreversible. 
Changes on TDS activity and oxidation of thiol groups 
of a cystein-dependent protein region of the 
mitochondrial internal membranes cause depolarization 
and destabilization of the mitochondrial internal 
membranes, with so called non-selective PT-pore 
(permeability transition pore – PTP) being formed . 
Opening of such channel in the internal membrane 
results in establishing ion balance in the matrix and 
mitochondrial intermembranous space, distributes 
hydrogen ion gradient (Н
+) to the internal membrane 
and breaks respiratory chain. Also, this causes volume 
disregulation of mitochondria due to the matrix 
hyperosmolality, results in the increased matrix volume, 
breaks of the external membrane and growing 
destabilization of mitochondria and enzyme system, 
leads to development of persistent mitochondrial 
dysfunction, and as a result, to mitochondrial death – 
mitoptosis. Moreover, IL-1, produced in response to 
hypoxia, expresses inducible NOS (iNOS) in the glial 
cells, which results in NO hyperproduction and toxic 
effects die to its excessive amount.  Excessive amount 
and its highly toxic derivatives nitrosylate protein-
clinging enzymes of the respiratory chain of 
mitochondria and Krebs cycle, and inhibit them. 
Dysfunction of mitochondrial enzyme complexes 
(MEC) is formed, which causes qualitative changes of 
iron-sulfur centers in the mitochondrial enzymes and 
their functions, as well as suppression of a main (NAD-
dependent) pathway for the substrate oxidation in 
respiratory chain. Aerobic energy synthesis is 
suppressed, thus bioenergetic (tissue) hypoxia is 
developed.  Under conditions of the impaired generation
of cell energy, caused by mitochondrial dysfunction, 
loss of NAD and ATP results in death of cells by 
necrosis or apoptosis. These pathophysiological changes
form the basis of occurrence of early or late post-
ischemic DM complications, resulting in disturbance of 
the usual lifestyle and lowering of life quality, persistent
loss of occupational capacity and rapid progression of 
heavy neurological consequences up to lethal outcome. 
To gain maximum protective effect in the DM therapy, it
is necessary to achieve interruption of pathogenetic 
ischemic/hypoxic cascade at earlier stages, which 
includes stage of thiol-disulfide imbalance establishing. 
Normalization of TDS state allows prevention of 
depolarization and destabilization of the mitochondrial 
internal membrane followed by development of 
mitochondrial dysfunction, energy imbalance and other 
post-ischemic consequences.
Keywords: interleukin-1, IL-1ra, experimental 
diabetes mellitus, thiol-disulfide system